一种用于儿科遗传性的拼接切换反感性寡核酸方法
Haley B Dame1,2, Hema Kopalle3,4,5, Belen Miñana6
1Genetics, Molecular and Cell Biology Program, Tufts University School of Medicine, Boston, MA, United States.
bioRxiv : the preprint server for biology
|November 24, 2025
概括
反感性寡核酸 (ASO) 为SCN8A相关的儿科提供了一种新的治疗方法. 这些ASO纠正异常的基因拼接,减少发作和改善小鼠模型的结果.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 儿科常常是由离子通道基因中的遗传变异引起的.
- SCN8A基因变异约占遗传性的1%,与严重的表型有关.
- SCN8A外因子5N和5A的替代拼接会影响疾病的表现,特别是婴儿.
研究的目的:
- 为了研究SCN8A替代性外显子5拼接在儿科中的作用.
- 作为一种治疗策略,开发和测试拼接切换反感性寡核酸 (ASO).
主要方法:
- 对SCN8A外因子5变体及其对拼接和患者表型的影响的分析.
- 开发反感性寡核化物 (ASO) 来调节SCN8A外子拼接.
- 在患者衍生的iPSC神经元和新型SCN8A外因子5N突变小鼠模型中测试ASO疗效.
主要成果:
- 在SCN8A替代异构5N和5A中的变异与婴儿有关,并影响拼接.
- ASOs成功地在两个方向上转移了SCN8A外因子拼接.
- 在iPSC模型中,ASO治疗使神经元活动正常化,并在小鼠模型中减少发作,运动障碍和延长寿命.
结论:
- 拼接切换ASO代表了SCN8A相关的有前途的治疗方法.
- 这种策略可以纠正致病性SCN8A异型,并拯救和非表型.
- ASO方法可能适用于其他涉及离子通道基因替代拼接的儿科遗传.
更多相关视频
10:30Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
19.2K
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
1.3K
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
799
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
799
siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
